{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:02:28Z","timestamp":1795050148965,"version":"4.10.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20241951"],"award-info":[{"award-number":["BK20241951"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202856"],"award-info":[{"award-number":["82202856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M702754"],"award-info":[{"award-number":["2021M702754"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioma is the most common primary tumor in the central nervous system, with glioblastoma (GBM) representing one of the most malignant forms, accounting for 46.1% of cases. GBM is characterized by rapid progression, high malignancy, and poor prognosis, with median survival remaining less than 15 months despite combined surgery, radiotherapy, and chemotherapy. NAT10, the only known acetyltransferase mediating N4-acetylcytidine (ac4C) modification in eukaryotes, has been implicated in promoting tumorigenesis and progression in colon cancer, bladder cancer, pancreatic ductal cancer, among others. In this study, we found that NAT10 is highly expressed in GBM and is positively correlated with malignant pathological features and poor prognosis in patients. In vitro experiments demonstrated that NAT10 promotes tumor proliferation, migration, and invasion. In vivo experiments further confirmed that NAT10 facilitates malignant progression of tumors. Mechanistically, we revealed that NAT10 regulates PIK3R2 stabilization through ac4C modification, thereby participating malignant characterization of GBM. Additionally, our data demonstrated a positive correlation between NAT10 and PIK3R2 in glioma patients. Taken together, our findings strongly suggest that NAT10 is a potential therapeutic target for GBM.<\/jats:p>","DOI":"10.1038\/s41419-025-08328-y","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T07:25:16Z","timestamp":1765956316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["NAT10-mediated N4-acetylcytidine (ac4C) modification of PIK3R2 mRNA promotes malignant progression of glioblastoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Xiannan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingding","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1524-7893","authenticated-orcid":false,"given":"Jin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"8328_CR1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","volume":"35","author":"BM Alexander","year":"2017","unstructured":"Alexander BM, Cloughesy TF. Adult glioblastoma. J Clin Oncol. 2017;35:2402\u20139.","journal-title":"J Clin Oncol"},{"key":"8328_CR2","doi-asserted-by":"crossref","unstructured":"Targeted glioma therapy makes strides. Nat Biotechnol. 2023;41:884.","DOI":"10.1038\/s41587-023-01869-7"},{"key":"8328_CR3","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41388-023-02746-y","volume":"42","author":"C Piperi","year":"2023","unstructured":"Piperi C, Markouli M, Gargalionis AN, Papavassiliou KA, Papavassiliou AG. Deciphering glioma epitranscriptome: focus on RNA modifications. Oncogene. 2023;42:2197\u2013206.","journal-title":"Oncogene"},{"key":"8328_CR4","doi-asserted-by":"publisher","first-page":"628415","DOI":"10.3389\/fcell.2021.628415","volume":"9","author":"S Kumar","year":"2021","unstructured":"Kumar S, Mohapatra T. Deciphering epitranscriptome: modification of mRNA bases provides a new perspective for post-transcriptional regulation of gene expression. Front Cell Dev Biol. 2021;9:628415.","journal-title":"Front Cell Dev Biol"},{"key":"8328_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s12276-020-0407-z","volume":"52","author":"SH Boo","year":"2020","unstructured":"Boo SH, Kim YK. The emerging role of RNA modifications in the regulation of mRNA stability. Exp Mol Med. 2020;52:400\u20138.","journal-title":"Exp Mol Med"},{"key":"8328_CR6","doi-asserted-by":"publisher","first-page":"115628","DOI":"10.1016\/j.bcp.2023.115628","volume":"213","author":"J Luo","year":"2023","unstructured":"Luo J, Cao J, Chen C, Xie H. Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges. Biochem Pharmacol. 2023;213:115628.","journal-title":"Biochem Pharmacol"},{"key":"8328_CR7","doi-asserted-by":"publisher","first-page":"127789","DOI":"10.1016\/j.ijbiomac.2023.127789","volume":"254","author":"L Wang","year":"2024","unstructured":"Wang L, Tao Y, Zhai J, Xue M, Zheng C, Hu H. The emerging roles of ac4C acetylation \u201cwriter\u201d NAT10 in tumorigenesis: a comprehensive review. Int J Biol Macromol. 2024;254:127789.","journal-title":"Int J Biol Macromol"},{"key":"8328_CR8","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, et al. NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res. 2023;83:1666\u201383.","journal-title":"Cancer Res"},{"key":"8328_CR9","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1016\/j.apsb.2022.01.015","volume":"12","author":"R Wei","year":"2022","unstructured":"Wei R, Cui X, Min J, Lin Z, Zhou Y, Guo M, et al. NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma. Acta Pharm Sin B. 2022;12:3313\u201325.","journal-title":"Acta Pharm Sin B"},{"key":"8328_CR10","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1093\/nar\/gkaa130","volume":"48","author":"HY Liu","year":"2020","unstructured":"Liu HY, Liu YY, Yang F, Zhang L, Zhang FL, Hu X, et al. Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer. Nucleic Acids Res. 2020;48:3638\u201356.","journal-title":"Nucleic Acids Res"},{"key":"8328_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Zhang M, Zhang Y, Xie Y, Zou J, Zhong J, et al. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med. 2022;12:e738.","journal-title":"Clin Transl Med"},{"key":"8328_CR12","doi-asserted-by":"crossref","unstructured":"Zhao CC, Sun X, Chen J, Geng BD. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression. Thorac Cancer. 2024;15:820\u20139.","DOI":"10.1111\/1759-7714.15262"},{"key":"8328_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jing Y, Wang Y, Tang J, Zhu X, Jin WL, et al. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct Target Ther. 2021;6:173.","journal-title":"Signal Transduct Target Ther"},{"key":"8328_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41368-023-00276-7","volume":"16","author":"X Wang","year":"2024","unstructured":"Wang X, Ling R, Peng Y, Qiu W, Chen D. RNPS1 stabilizes NAT10 protein to facilitate translation in cancer via tRNA ac(4)C modification. Int J Oral Sci. 2024;16:6.","journal-title":"Int J Oral Sci"},{"key":"8328_CR15","doi-asserted-by":"publisher","first-page":"108544","DOI":"10.1016\/j.jbc.2025.108544","volume":"301","author":"T Inoki","year":"2025","unstructured":"Inoki T, Tsuruta A, Masakado Y, Kai Y, Yoshida Y, Matsunaga N, et al. N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2. J Biol Chem. 2025;301:108544.","journal-title":"J Biol Chem"},{"key":"8328_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02338-2","volume":"24","author":"H Allgayer","year":"2025","unstructured":"Allgayer H, Mahapatra S, Mishra B, Swain B, Saha S, Khanra S, et al. Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025. Mol Cancer. 2025;24:167.","journal-title":"Mol Cancer"},{"key":"8328_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12184-8","volume":"10","author":"RC Wu","year":"2019","unstructured":"Wu RC, Young IC, Chen YF, Chuang ST, Toubaji A, Wu MY. Identification of the PTEN-ARID4B-PI3K pathway reveals the dependency on ARID4B by PTEN-deficient prostate cancer. Nat Commun. 2019;10:4332.","journal-title":"Nat Commun"},{"key":"8328_CR18","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1111\/cas.15387","volume":"113","author":"J Zhou","year":"2022","unstructured":"Zhou J, Xu N, Liu B, Wang C, He Z, Lenahan C, et al. lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K\/AKT pathway in glioma. Cancer Sci. 2022;113:2681\u201392.","journal-title":"Cancer Sci"},{"key":"8328_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 2017;32:42\u201356 e46.","journal-title":"Cancer Cell"},{"key":"8328_CR20","doi-asserted-by":"crossref","unstructured":"Fedele M, Cerchia L, Pegoraro S, Sgarra R, Manfioletti G. Proneural-mesenchymal transition: phenotypic plasticity to acquire multitherapy resistance in glioblastoma. Int J Mol Sci. 2019;20:2746.","DOI":"10.3390\/ijms20112746"},{"key":"8328_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/neuonc\/not239","volume":"16","author":"R Mahabir","year":"2014","unstructured":"Mahabir R, Tanino M, Elmansuri A, Wang L, Kimura T, Itoh T, et al. Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. Neuro Oncol. 2014;16:671\u201385.","journal-title":"Neuro Oncol"},{"key":"8328_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2016.01.005","volume":"29","author":"SH Kim","year":"2016","unstructured":"Kim SH, Ezhilarasan R, Phillips E, Gallego-Perez D, Sparks A, Taylor D, et al. Serine\/threonine kinase MLK4 determines mesenchymal identity in glioma stem cells in an NF-kappaB-dependent manner. Cancer Cell. 2016;29:201\u201313.","journal-title":"Cancer Cell"},{"key":"8328_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-020-01641-8","volume":"39","author":"J Liu","year":"2020","unstructured":"Liu J, Gao L, Zhan N, Xu P, Yang J, Yuan F, et al. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma. J Exp Clin Cancer Res. 2020;39:137.","journal-title":"J Exp Clin Cancer Res"},{"key":"8328_CR24","doi-asserted-by":"crossref","unstructured":"Khezri MR, Hsueh HY, Mohammadipanah S, Khalili Fard J, Ghasemnejad-Berenji M. The interplay between the PI3K\/AKT pathway and circadian clock in physiologic and cancer-related pathologic conditions. Cell Prolif. 2024;57:e13608.","DOI":"10.1111\/cpr.13608"},{"key":"8328_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47985-z","volume":"15","author":"C Pichol-Thievend","year":"2024","unstructured":"Pichol-Thievend C, Anezo O, Pettiwala AM, Bourmeau G, Montagne R, Lyne AM, et al. VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance. Nat Commun. 2024;15:3602.","journal-title":"Nat Commun"},{"key":"8328_CR26","doi-asserted-by":"publisher","first-page":"154990","DOI":"10.1016\/j.prp.2023.154990","volume":"253","author":"P Rodrigues","year":"2024","unstructured":"Rodrigues P, Bangali H, Ali E, Nauryzbaevish AS, Hjazi A, Fenjan MN, et al. The mechanistic role of NAT10 in cancer: unraveling the enigmatic web of oncogenic signaling. Pathol Res Pract. 2024;253:154990.","journal-title":"Pathol Res Pract"},{"key":"8328_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15252\/embr.201540505","volume":"17","author":"X Liu","year":"2016","unstructured":"Liu X, Tan Y, Zhang C, Zhang Y, Zhang L, Ren P, et al. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016;17:349\u201366.","journal-title":"EMBO Rep"},{"key":"8328_CR28","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell. 2018;175:1872\u20131886 e1824.","journal-title":"Cell"},{"key":"8328_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202106058","volume":"9","author":"K Wang","year":"2022","unstructured":"Wang K, Zhou LY, Liu F, Lin L, Ju J, Tian PC, et al. PIWI-interacting RNA HAAPIR regulates cardiomyocyte death after myocardial infarction by promoting NAT10-mediated ac(4) C acetylation of Tfec mRNA. Adv Sci. 2022;9:e2106058.","journal-title":"Adv Sci"},{"key":"8328_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24573","volume":"10","author":"J Shen","year":"2024","unstructured":"Shen J, Sun Y, Zhuang Q, Xue D, He X. NAT10 promotes renal ischemia-reperfusion injury via activating NCOA4-mediated ferroptosis. Heliyon. 2024;10:e24573.","journal-title":"Heliyon"},{"key":"8328_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/bju.12603","volume":"114","author":"CL Parsons","year":"2014","unstructured":"Parsons CL, Shaw T, Berecz Z, Su Y, Zupkas P, Argade S. Role of urinary cations in the aetiology of bladder symptoms and interstitial cystitis. BJU Int. 2014;114:286\u201393.","journal-title":"BJU Int"},{"key":"8328_CR32","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y, Hu W, et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun. 2022;42:1347\u201366.","journal-title":"Cancer Commun"},{"key":"8328_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302705","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Hao Y, Liu Y, Zhong S, You Y, Ao K, et al. NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer. Adv Sci. 2023;10:e2302705.","journal-title":"Adv Sci"},{"key":"8328_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37361-8","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Soni N, Pinero G, Giotti B, Eddins DJ, Lindblad KE, et al. Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma. Nat Commun. 2023;14:1839.","journal-title":"Nat Commun"},{"key":"8328_CR35","doi-asserted-by":"publisher","first-page":"iii281","DOI":"10.1093\/neuonc\/noy139.247","volume":"20","author":"F Cheng","year":"2018","unstructured":"Cheng F, Mao F, Xiao Q, Wang B, Guo D. P04.13 LRIG3 and Soluble LRIG3 Ectodomain both inhibit the Proliferation and Invasion of Glioma cells in vitro and in vivo through modulation of Met-PI3K-Akt pathway. Neuro-Oncology. 2018;20:iii281.","journal-title":"Neuro-Oncology"},{"key":"8328_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/science.1252651","volume":"344","author":"D Larrieu","year":"2014","unstructured":"Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science. 2014;344:527\u201332.","journal-title":"Science"},{"key":"8328_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84908-0","volume":"11","author":"MH Dalhat","year":"2021","unstructured":"Dalhat MH, Altayb HN, Khan MI, Choudhry H. Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors. Sci Rep. 2021;11:6051.","journal-title":"Sci Rep"},{"key":"8328_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.chom.2020.05.011","volume":"28","author":"K Tsai","year":"2020","unstructured":"Tsai K, Jaguva Vasudevan AA, Martinez Campos C, Emery A, Swanstrom R, Cullen BR. Acetylation of cytidine residues boosts HIV-1 gene expression by increasing viral RNA stability. Cell Host Microbe. 2020;28:306\u2013312.e306.","journal-title":"Cell Host Microbe"},{"key":"8328_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03770-3","volume":"9","author":"G Balmus","year":"2018","unstructured":"Balmus G, Larrieu D, Barros AC, Collins C, Abrudan M, Demir M, et al. Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome. Nat Commun. 2018;9:1700.","journal-title":"Nat Commun"},{"key":"8328_CR40","first-page":"7561879","volume":"2019","author":"X Zhang","year":"2019","unstructured":"Zhang X, Chen J, Jiang S, He S, Bai Y, Zhu L, et al. N-acetyltransferase 10 enhances doxorubicin resistance in human hepatocellular carcinoma cell lines by promoting the epithelial-to-mesenchymal transition. Oxid Med Cell Longev. 2019;2019:7561879.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08328-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:53:18Z","timestamp":1769532798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08328-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8328"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08328-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted following approval by the Institutional Animal Care and Use Committee of Xuzhou Medical University (202309T015). All treatments were administered in accordance with the guidelines established by the committee. The clinicopathological data of the patients were obtained from the medical records of the Affiliated Hospital of Xuzhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"106"}}